XenoPort, Inc. (NASDAQ:XNPT)

TMFBiologyFool (98.28) Submitted: 11/10/2008 11:00:30 AM : Start Price: $34.50 XNPT Score: -127.96

Purely a value play. Doesn't deserve a 13% drop because Solzira's NDA has to be reformatted.

mukwonago53149 (< 20) Submitted: 1/16/2008 9:24:14 PM : Start Price: $61.40 XNPT Score: +90.32

http://www.fool.com/investing/small-cap/2008/01/16/stocks-on-bubble-watch.aspx

JakeTomato (39.80) Submitted: 1/11/2008 12:41:37 PM : Start Price: $60.83 XNPT Score: -88.15

Valuable potential medical technology for a variety of common clinical problems.

morningstarboy (32.35) Submitted: 12/5/2007 1:03:04 PM : Start Price: $54.49 XNPT Score: +82.42

As of close of business on 12/04/2007, this was a 1-star Morningstar stock that was trading at more than double it's Morningstar fair value.

WiseWallstWhiz (< 20) Submitted: 8/20/2007 4:21:36 PM : Start Price: $39.57 XNPT Score: -81.31

Xenoport's drug delivery technology shows great promise given its pairing with GSK's restless leg syndrome drug and their recent partnership agreement expected to bring in cashflows north of $600M upon hitting milestones....Right now in Phase III clinical trials...Most importantly this companies drug delivery technology can be paired with various drugs on the market giving it ultimately a great platform to build a solid business upon....

indexmagnet (35.12) Submitted: 5/14/2007 5:59:04 PM : Start Price: $40.79 XNPT Score: -78.26

Rare non binary biotech. Pro-drug transporter works, pipeline good -RLS/GERD/Migraine/Parkinsons. May get taken out by big pharma or become big pharma. Each way bet.

majakblue (< 20) Submitted: 4/25/2007 11:34:26 PM : Start Price: $40.20 XNPT Score: -78.80

They have a product in phase III trials. Stock will keep going up until product goes kapluuie or executives start buying castles. Pull out of this one if there is a negative report on the product!